Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shanghai Chenguang Medical Technologies Co Days Payable?
Shanghai Chenguang Medical Technologies CoBJSE:920300 53 Days Payable is 87.19 as of Mar. 2026, which is 19% above its 10-year median of 73.43. GuruFocus rates BJSE:920300 with a GF Score™ of 53/100 and a GF Value™ of ¥6.57 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 2,996 Industrial Products companies, Shanghai Chenguang Medical Technologies Co ranks better than 75.03% on this metric.
BJSE:920300's Days Payable is ranked better than 75.03% of 2996
companies
in the Industrial Products industry
Industry Median: 78.01
vs BJSE:920300: 146.55
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Chenguang Medical Technologies Co Days Payable Chart
Shanghai Chenguang Medical Technologies Co Annual Data
For the Electrical Equipment & Parts subindustry, Shanghai Chenguang Medical Technologies Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Chenguang Medical Technologies Co Days Payable vs Industrial Products Industry
Shanghai Chenguang Medical Technologies Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Chenguang Medical Technologies Co (BJSE:920300) has a Days Payable of 87.19 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors. This is 19% above median its historical median of 73.43. Over the past decade, Shanghai Chenguang Medical Technologies Co's Days Payable has ranged from 52.48 to 146.55. According to the industry distribution chart, Shanghai Chenguang Medical Technologies Co ranks #748 out of 2996 companies in the Industrial Products industry, placing it in the top 25%.
Is Shanghai Chenguang Medical Technologies Co's Days Payable too high?
Shanghai Chenguang Medical Technologies Co's current Days Payable of 87.19 is 19% above median its 10-year median of 73.43. Over the past 10 years, this metric has ranged from a low of 52.48 to a high of 146.55. The Industrial Products industry median Days Payable is 78.01. Shanghai Chenguang Medical Technologies Co's value of 87.19 is 11.8% above this industry median. Based on the distribution chart, Shanghai Chenguang Medical Technologies Co ranks #748 out of 2996 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Chenguang Medical Technologies Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Chenguang Medical Technologies Co's Days Payable compare to VRT and BE?
According to the Industrial Products industry distribution chart, Shanghai Chenguang Medical Technologies Co ranks #748 out of 2996 companies for Days Payable. This places Shanghai Chenguang Medical Technologies Co in the top 25% of its industry — outperforming the majority of peers. The industry median Days Payable is 78.01. Shanghai Chenguang Medical Technologies Co's value of 87.19 is 11.8% above this benchmark. Historically, Shanghai Chenguang Medical Technologies Co's own Days Payable has ranged from 52.48 to 146.55 over the past decade. While the company's 10-year median is 73.43 vs. the industry median of 78.01, Shanghai Chenguang Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for an Industrial Products company?
The median Days Payable among Industrial Products companies is 78.01, based on 2,996 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Chenguang Medical Technologies Co's current Days Payable of 87.19 is 11.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors. For the Industrial Products industry, the median Days Payable is 78.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Chenguang Medical Technologies Co's current Days Payable is 87.19, which is 19% above median its own 10-year median of 73.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Chenguang Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co (BJSE:920300) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥6.57, compared to a current price of ¥9.47 — trading 44.1% above its estimated fair value. The current Days Payable is 87.19, which is 19% above median its 10-year median of 73.43 and 11.8% above the Industrial Products industry median of 78.01. Shanghai Chenguang Medical Technologies Co's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai Chenguang Medical Technologies Co (BJSE:920300), the current Days Payable is 87.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Chenguang Medical Technologies Co (BJSE:920300) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co stock appears to be overvalued.
The current stock price of ¥9.47 is trading 44.1% above its estimated GF Value™ of ¥6.57.
GuruFocus considers Shanghai Chenguang Medical Technologies Co to be Significantly Overvalued.
Key valuation signals for BJSE:920300:
Days Payable: 87.19 (19% above median its 10-year median of 73.43)
GF Value™: ¥6.57 vs. price of ¥9.47 (44.1% above fair value)
Industry Position: 11.8% above the Industrial Products median (#748 of 2996)
No single metric tells the full story. See the BJSE:920300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Chenguang Medical Technologies Co Ltd engages in research and development, production, and sales of the core hardware of medical imaging superconducting MRI equipment and special magnets in the field of scientific research. The company's product system covers hardware of superconducting MRI devices, including: RF detectors, superconducting magnets, gradient coils, RF amplifiers, gradient amplifiers.
53GF Score
Get the complete analysis for BJSE:920300
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920300 has been successfully added to your 
